These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The relative value of fecal occult blood tests and flexible sigmoidoscopy in screening for large bowel neoplasia. Rozen P; Ron E; Fireman Z; Hallak A; Grossman A; Baratz M; Rattan J; Gilat T Cancer; 1987 Nov; 60(10):2553-8. PubMed ID: 3664435 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity of fecal hemoccult testing and flexible sigmoidoscopy for colorectal cancer screening. Bang KM; Tillett S; Hoar SK; Blair A; McDougall V J Occup Med; 1986 Aug; 28(8):709-13. PubMed ID: 3746495 [TBL] [Abstract][Full Text] [Related]
6. Screening/early detection model for colorectal cancer. Why screen? Lieberman D Cancer; 1994 Oct; 74(7 Suppl):2023-7. PubMed ID: 8087765 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Sonnenberg A; Delcò F; Inadomi JM Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584 [TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer screening: new opportunities. Levin TR Surg Oncol Clin N Am; 1999 Oct; 8(4):673-91, vi-vii. PubMed ID: 10452934 [TBL] [Abstract][Full Text] [Related]
12. Results of screening for colorectal cancer. Crespi M; Casale V; Grassi A; Caperle M; Casale G; Conti E Endoscopy; 1981 Sep; 13(5):203-6. PubMed ID: 7274170 [TBL] [Abstract][Full Text] [Related]
13. Surveillance for colorectal cancer in average-risk patients, familial high-risk groups, and patients with adenomas. Winawer SJ; Sherlock P Cancer; 1982 Dec; 50(11 Suppl):2609-14. PubMed ID: 7139555 [TBL] [Abstract][Full Text] [Related]
14. [Screening and prevention of carcinoma of the colon and rectum]. Weber C Ther Umsch; 2006 May; 63(5):333-7. PubMed ID: 16739892 [TBL] [Abstract][Full Text] [Related]
15. How good is screening for colorectal cancer? Nostrant TT; Wilson JA Postgrad Med; 1983 Jun; 73(6):131-9. PubMed ID: 6856522 [TBL] [Abstract][Full Text] [Related]
17. Screening flexible sigmoidoscopy by primary care physicians. Effectiveness and costs in patients negative for fecal occult blood. Rumans MC; Benner KG; Keeffe EB; Custis JM; Lockwood DR; Craner GE West J Med; 1986 Jun; 144(6):756-8. PubMed ID: 3088841 [TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer screening in average risk individuals. Huang CS; Lal SK; Farraye FA Cancer Causes Control; 2005 Mar; 16(2):171-88. PubMed ID: 15868457 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of screening for colorectal cancer in Japan. Tsuji I; Fukao A; Shoji T; Kuwajima I; Sugawara N; Hisamichi S Tohoku J Exp Med; 1991 Aug; 164(4):269-78. PubMed ID: 1746016 [TBL] [Abstract][Full Text] [Related]
20. Current status of fecal occult blood testing in screening for colorectal cancer. Winawer SJ; Fleisher M; Baldwin M; Sherlock P CA Cancer J Clin; 1982; 32(2):100-12. PubMed ID: 6800588 [No Abstract] [Full Text] [Related] [Next] [New Search]